Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges.
Current preclinical and clinical evidence from 2019 to 2026 for gene-edited hypoimmune islets is critically evaluated, highlighting key immunological vulnerabilities that may emerge over time and whether these long-term challenges can be overcome.
Ahmed Hassanein, F. Cyprian, Saghir Akhtar
· Expert Opinion on Biological... · 0 citations